Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Cheers to Growth: Constellation Brands Gets Upgrade, Analyst Bullish on Beer Sales

By Shivani Kumaresan
April 15, 1:57 PM
Constellation Brands gets a Buy rating upgrade from Argus Research analyst John Staszak, with a bullish price target of $306. Fiscal Q4 2024 saw a 7% rise in comparable sales to $2.14 billion, surpassing estimates. Beer revenue surged by approximately 11%, boosting overall sales, leading to an optimistic EPS outlook for FY25 and FY26.

STZ

Read More
1 minute read

Ecolab Returning As A Consistent Earnings Compounder, Says Analyst

By Shivani Kumaresan
April 12, 1:15 PM
Ecolab receives a bullish boost as Mizuho analyst John Roberts upgrades its shares from Neutral to Buy, elevating the price target to $260 from $216. Roberts notes ECL's return to historical performance trends, with nearly 25 years of meeting or surpassing quarterly estimates pre-pandemic.

ECL

Read More
2 minute read

Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact

By Vandana Singh
April 11, 2:47 PM
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

ALPN